Assessing whether Centene Corporation (NYSE: CNC) is a good buy right now involves weighing attractive valuation multiples against ongoing healthcare sector policy risks. Financial metrics indicate that the stock trades at a notable discount relative to its peers on a price-to-sales basis, supported by strong revenue performance and ongoing cost-management initiatives. While consensus analyst ratings lean toward a neutral hold, value-oriented investors often eye its strong fundamentals and market positioning for long-term upside potential.